Status:
COMPLETED
Comparison Between Effect of Acetazolamide and NaHco3 in Prevention of Contrast Nephropathy
Lead Sponsor:
Shiraz University of Medical Sciences
Collaborating Sponsors:
Fars Heart Foundation
Conditions:
Contrast Induced Nephropathy
Eligibility:
All Genders
18-80 years
Phase:
PHASE2
Brief Summary
The purpose of this study is whether Acetazolamide is effective in prevention of contrast nephropathy
Detailed Description
Contrast induced nephropathy is one of common causes of acute renal failure many preventive protocol existed . 240 patient that underwent coronary angiography randomly divided in three groups.Group 1,...
Eligibility Criteria
Inclusion
- patient that underwent coronary angiography
Exclusion
- serum Cr. more than 3 mg/dl
- electrolyte and acid-base imbalance
- pulmonary edema
- allergy to Acetazolamide
Key Trial Info
Start Date :
September 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2008
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT00634491
Start Date
September 1 2007
End Date
February 1 2008
Last Update
March 13 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fars Heart Foundation , Kowsar hospital
Shiraz, Iran